Cantor Fitzgerald analyst Prakhar Agrawal initiated coverage of Madrigal Pharmaceuticals with a Neutral rating.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDGL:
- Madrigal Pharmaceuticals Enhances Stock Plan and Re-elects Board
- Biotech Alert: Searches spiking for these stocks today
- Akero Therapeutics initiated with an Outperform at Wolfe Research
- Madrigal Pharmaceuticals initiated with an Outperform at Wolfe Research
- 3 Best Stocks to Buy Now, 6/10/2024, According to Top Analysts
Questions or Comments about the article? Write to editor@tipranks.com